149 related articles for article (PubMed ID: 16705085)
1. Analysis of fibrinogen variants at gamma387Ile shows that the side chain of gamma387 and the tertiary structure of the gammaC-terminal tail are important not only for assembly and secretion of fibrinogen but also for lateral aggregation of protofibrils and XIIIa-catalyzed gamma-gamma dimer formation.
Kani S; Terasawa F; Yamauchi K; Tozuka M; Okumura N
Blood; 2006 Sep; 108(6):1887-94. PubMed ID: 16705085
[TBL] [Abstract][Full Text] [Related]
2. Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma 275C, gamma 275H, and gamma 275A.
Hirota-Kawadobora M; Terasawa F; Suzuki T; Tozuka M; Sano K; Okumura N
J Thromb Haemost; 2004 Aug; 2(8):1359-67. PubMed ID: 15304042
[TBL] [Abstract][Full Text] [Related]
3. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
5. Substitution of the gamma-chain Asn308 disturbs the D:D interface affecting fibrin polymerization, fibrinopeptide B release, and FXIIIa-catalyzed cross-linking.
Okumura N; Gorkun OV; Terasawa F; Lord ST
Blood; 2004 Jun; 103(11):4157-63. PubMed ID: 14764520
[TBL] [Abstract][Full Text] [Related]
6. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
[TBL] [Abstract][Full Text] [Related]
8. Analysis of fibrinogen gamma-chain truncations shows the C-terminus, particularly gammaIle387, is essential for assembly and secretion of this multichain protein.
Okumura N; Terasawa F; Tanaka H; Hirota M; Ota H; Kitano K; Kiyosawa K; Lord ST
Blood; 2002 May; 99(10):3654-60. PubMed ID: 11986220
[TBL] [Abstract][Full Text] [Related]
9. Severely impaired polymerization of recombinant fibrinogen gamma-364 Asp --> His, the substitution discovered in a heterozygous individual.
Okumura N; Gorkun OV; Lord ST
J Biol Chem; 1997 Nov; 272(47):29596-601. PubMed ID: 9368024
[TBL] [Abstract][Full Text] [Related]
10. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation.
Lounes KC; Ping L; Gorkun OV; Lord ST
Biochemistry; 2002 Apr; 41(16):5291-9. PubMed ID: 11955079
[TBL] [Abstract][Full Text] [Related]
11. Recombinant variant fibrinogens substituted at residues gamma326Cys and gamma339Cys demonstrated markedly impaired secretion of assembled fibrinogen.
Haneishi A; Terasawa F; Fujihara N; Yamauchi K; Okumura N; Katsuyama T
Thromb Res; 2009 Jul; 124(3):368-72. PubMed ID: 19419756
[TBL] [Abstract][Full Text] [Related]
12. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
Hirota-Kawadobora M; Kani S; Terasawa F; Fujihara N; Yamauchi K; Tozuka M; Okumura N
J Thromb Haemost; 2005 May; 3(5):983-90. PubMed ID: 15869595
[TBL] [Abstract][Full Text] [Related]
14. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
[TBL] [Abstract][Full Text] [Related]
15. Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.
Ishikawa S; Hirota-Kawadobora M; Tozuka M; Ishii K; Terasawa F; Okumura N
J Thromb Haemost; 2004 Mar; 2(3):468-75. PubMed ID: 15009465
[TBL] [Abstract][Full Text] [Related]
16. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
17. Substitution of the human αC region with the analogous chicken domain generates a fibrinogen with severely impaired lateral aggregation: fibrin monomers assemble into protofibrils but protofibrils do not assemble into fibers.
Ping L; Huang L; Cardinali B; Profumo A; Gorkun OV; Lord ST
Biochemistry; 2011 Oct; 50(42):9066-75. PubMed ID: 21932842
[TBL] [Abstract][Full Text] [Related]
18. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
Okumura N; Terasawa F; Haneishi A; Fujihara N; Hirota-Kawadobora M; Yamauchi K; Ota H; Lord ST
J Thromb Haemost; 2007 Dec; 5(12):2352-9. PubMed ID: 17922804
[TBL] [Abstract][Full Text] [Related]
19. γD318Y fibrinogen shows no fibrin polymerization due to defective "A-a" and "B-b" interactions, whereas that of γK321E fibrinogen is nearly normal.
Kamijo T; Mukai S; Taira C; Higuchi Y; Okumura N
Thromb Res; 2019 Oct; 182():150-158. PubMed ID: 31484085
[TBL] [Abstract][Full Text] [Related]
20. A novel fibrinogen variant (fibrinogen Seoul II; AalphaGln328Pro) characterized by impaired fibrin alpha-chain cross-linking.
Park R; Doh HJ; An SS; Choi JR; Chung KH; Song KS
Blood; 2006 Sep; 108(6):1919-24. PubMed ID: 16735602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
